-
Policy Matters
The Future of Perioperative Clinical Trial DesignsA recent FDA-AACR workshop explored best practices for trial design, analysis and interpretation of clinical studies with multiple phases of treatment.
by Elizabeth M. Jaffee, MD
-
Patients as Research PartnersNew platforms allow patients to share their clinical data and tumor tissue no matter where they live, offering everyone a chance to participate in research.
by Erin O'Donnell
-
Get Involved
Happy FeetThe HallieStrong Foundation sends people receiving cancer treatment socks designed to put smiles on their faces.
by Thomas Celona
-
Advocacy After LossFollowing her son’s death from peripheral T-cell lymphoma, Sandy McHugh keeps his memory alive through Jake’s Dragon Foundation.
by Thomas Celona
-
Get Involved
Ground SupportHouston-based nonprofit offers free rides to and from medical appointments for people with cancer.
by Thomas Celona
-
Policy Matters
Clinical Trial Endpoints for Timely Drug DevelopmentAs patients live longer with cancer, scientists need to rethink how to determine if a new drug is safe and effective.
by Kenneth Anderson, MD
-
Taking Answers HomeAdvocates bring the patient perspective to the AACR Annual Meeting 2024 and leave with tools to better communicate advances in care to others.
by Eric Fitzsimmons
-
Get Involved
Creating ConnectionsChemo Companions ensures people with cancer do not have to be alone during their chemotherapy treatments.
by Thomas Celona
-
Policy Matters
Cancer Research Funding Faces Uncertain FutureThe AACR is planning numerous initiatives in 2024 to bolster congressional support.
by Jon Retzlaff, MBA, MPA
-
Doctors Urge Need for ‘Common Sense Oncology’A movement of health care professionals say the toll of many cancer treatments is out of sync with the purported benefits.
by Kyle Bagenstose
U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
